Medicenna Reports Second Quarter Fiscal 2022 Financial Results and Operational Highlights

NEXT STORY
Iovance Biotherapeutics Announces Clinical Data for LN-145 in Non-Small Cell Lung Cancer at Society for Immunotherapy of Cancer (SITC) Annual Meeting
PREV STORY
Global $32.67 Billion Bioethanol Yeast Market to 2028: Cleaning & Disinfection Segment Projected to Register the Fastest CAGR Over Forecast Period
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Tiziana Life Sciences plc: Early notification of proposed admission to the Official List and cancellation of trading on AIM

author_avatar
NASDAQ Market News

Clene Reports Full Year 2020 Operating and Financial Highlights

author_avatar
NASDAQ Market News

Novavax Initiates Phase 2 Portion of Phase 1/2 Clinical Trial of COVID-19 Vaccine

author_avatar
NASDAQ Market News